New reference pricing rule in Greece

After much debate the Greek Ministry of Economy, Competitiveness & Shipping has announced a new reference pricing law for pharmaceuticals. The struggling Greek economy is looking for opportunities to realize savings in the health care sector and has introduced a decree of mandatory price reductions. Depending on wholesale price reduction from -3% to -27% (drugs of over €100.01) will be implemented. Orphan drugs and blood derivates are excempted from that decree. This is supposed to be a temporary measure. At the same time a referencing rule of the lowest three countries in the Eurozone is being discussed and for orphan drugs three lowest plus Uk. I must say it is very confusing..it will be interesting to follow how this unfolds.

No comments: